Borderline over tümörlü 53 olgunun retrospektif analizi

[1]  E. Darai,et al.  Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. , 2012, The Lancet. Oncology.

[2]  P. Morice,et al.  How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  P. Harter,et al.  Clinical management of borderline ovarian tumors , 2010, Expert review of anticancer therapy.

[4]  V. Abeler,et al.  Diagnosis and treatment of borderline ovarian neoplasms "the state of the art". , 2009, European journal of gynaecological oncology.

[5]  I. Krajnc,et al.  Accuracy of Intra-Operative Frozen Section Analysis of Ovarian Tumours , 2009, The Journal of international medical research.

[6]  M. lenhard,et al.  Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[7]  J. Prat.  FIGO staging for uterine sarcomas , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8]  H. Klip,et al.  Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort , 2008 .

[9]  P. Neven,et al.  Management of borderline ovarian neoplasms. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  K. Hillaby,et al.  Accuracy of ultrasound subjective ‘pattern recognition’ for the diagnosis of borderline ovarian tumors , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[11]  A. Malpica,et al.  The Recurrence and the Overall Survival Rates of Ovarian Serous Borderline Neoplasms With Noninvasive Implants is Time Dependent , 2006, The American journal of surgical pathology.

[12]  F. Amant,et al.  Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy. , 2005, Gynecologic oncology.

[13]  I. Shih,et al.  Serous borderline tumours of the ovary , 2005, Histopathology.

[14]  J. McKenney,et al.  Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up , 2005, The American journal of surgical pathology.

[15]  E. Daraï,et al.  Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. , 2005, Fertility and sterility.

[16]  Z. Rosenwaks,et al.  Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report. , 2003, Fertility and sterility.

[17]  J. Prat.  Serous tumors of the ovary (borderline tumors and carcinomas) with and without micropapillary features. , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  A. Malpica,et al.  Micropapillary and Cribriform Patterns in Ovarian Serous Tumors of Low Malignant Potential: A Study of 99 Advanced Stage Cases , 2002, The American journal of surgical pathology.

[19]  B. Davidson,et al.  Borderline tumors of the ovary , 1998, Cancer.

[20]  V. Abeler,et al.  A retrospective study of 370 borderline tumors of the ovary treated at the norwegian radium hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities , 1993, Cancer.

[21]  J. Rader,et al.  Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. , 1991, Gynecologic oncology.